Erectile dysfunction drug boosts slumping Auxilium

Despite seeing sales of its testosterone replacement gel Testim plummet by 76 percent in the first quarter, Auxilium Pharmaceuticals’ overall first quarter revenues climbed by 34 percent based partly on revenues from its new erectile dysfunction drug Stendra...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.